Chemical genomics-based target identification and validation of anti-angiogenic agents

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

The recent use of chemical genomics to identify bioactive small molecules that interact with specific proteins has had a tremendous impact on both the functional analysis of genes and drug development. Accordingly, the current review focuses on the utilization of this new research engine in the target identification and validation of anti-angiogenic agents capable of regulating the growth and spread of cancer cells. In addition, the use of chemical genomics to discover novel anti-angiogenic agent targets and to validate their biological relevancy is providing new insights into the biological role of targets in angiogenesis as well as advancing the development of new anti-angiogenic agents.

Original languageEnglish
Pages (from-to)717-726
Number of pages10
JournalCurrent Medicinal Chemistry
Volume10
Issue number9
DOIs
Publication statusPublished - 2003 Apr 28

Fingerprint

Genomics
Functional analysis
Growth
Genes
Cells
Research
Pharmaceutical Preparations
Engines
Neoplasms
Proteins
Molecules

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

@article{c6f73686cb8e4e0bab1453f8c96a2a01,
title = "Chemical genomics-based target identification and validation of anti-angiogenic agents",
abstract = "The recent use of chemical genomics to identify bioactive small molecules that interact with specific proteins has had a tremendous impact on both the functional analysis of genes and drug development. Accordingly, the current review focuses on the utilization of this new research engine in the target identification and validation of anti-angiogenic agents capable of regulating the growth and spread of cancer cells. In addition, the use of chemical genomics to discover novel anti-angiogenic agent targets and to validate their biological relevancy is providing new insights into the biological role of targets in angiogenesis as well as advancing the development of new anti-angiogenic agents.",
author = "Kwon, {Ho Jeong}",
year = "2003",
month = "4",
day = "28",
doi = "10.2174/0929867033457755",
language = "English",
volume = "10",
pages = "717--726",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

Chemical genomics-based target identification and validation of anti-angiogenic agents. / Kwon, Ho Jeong.

In: Current Medicinal Chemistry, Vol. 10, No. 9, 28.04.2003, p. 717-726.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Chemical genomics-based target identification and validation of anti-angiogenic agents

AU - Kwon, Ho Jeong

PY - 2003/4/28

Y1 - 2003/4/28

N2 - The recent use of chemical genomics to identify bioactive small molecules that interact with specific proteins has had a tremendous impact on both the functional analysis of genes and drug development. Accordingly, the current review focuses on the utilization of this new research engine in the target identification and validation of anti-angiogenic agents capable of regulating the growth and spread of cancer cells. In addition, the use of chemical genomics to discover novel anti-angiogenic agent targets and to validate their biological relevancy is providing new insights into the biological role of targets in angiogenesis as well as advancing the development of new anti-angiogenic agents.

AB - The recent use of chemical genomics to identify bioactive small molecules that interact with specific proteins has had a tremendous impact on both the functional analysis of genes and drug development. Accordingly, the current review focuses on the utilization of this new research engine in the target identification and validation of anti-angiogenic agents capable of regulating the growth and spread of cancer cells. In addition, the use of chemical genomics to discover novel anti-angiogenic agent targets and to validate their biological relevancy is providing new insights into the biological role of targets in angiogenesis as well as advancing the development of new anti-angiogenic agents.

UR - http://www.scopus.com/inward/record.url?scp=0037265614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037265614&partnerID=8YFLogxK

U2 - 10.2174/0929867033457755

DO - 10.2174/0929867033457755

M3 - Review article

C2 - 12678774

AN - SCOPUS:0037265614

VL - 10

SP - 717

EP - 726

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 9

ER -